Mesenchymal Stem Cells

By G. Sukhikh, V. V. Malaitsev, I. M. Bogdanova, I. Dubrovina. Bulletin of experimental biology and medicine, 2002

5,203 citations recorded by the source corpus.

Subfields: Biomaterials, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/4b68cf333ff301437509b3e26630340f6f84e85e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

In Genetics

In Surgery

Citations in the corpus

Engineering Complex Tissues (2006, positive): “7 Arnold Caplan, a founding father of modern tissue engineering, described the vasculature as the ‘‘orientor of osteogenesis’’ in vivo , 8 and his illustrations make clear that it is the vessels of the periosteum that provide the (negative) model for newly apposed layers of bone.”
Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells (2012, neutral): “Since then, these cells have been extensively investigated and given various names, until Caplan proposed the definition ‘‘mesenchymal stem cells’’ (MSCs) in 1991 [4], which gained common usage.”
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. (2007, background): “The multipotency of at least a subset of CFU-Fs supports the view that a second type of stem cell (skeletal [Bianco and Robey, 2004], stromal [Owen and Friedenstein, 1988], or ‘‘mesenchymal’’ [Caplan, 1991]) coexists with HSCs in BM.”
Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications (2005, background): “…IGF-1, and PDGFs are key factors in supporting MSC ex vivo expansion and maintaining their multilineage potential for further differentiation (Gibbons et al., 1995; Cassiede et al., 1996; Hanada et al., 1997; Banfi et al., 2000; Muraglia et al., 2000; Tsutsumi et al., 2001; Walsh et al., 2003).”
Mechanisms involved in the therapeutic properties of mesenchymal stem cells. (2009, background): “This proposed non-hematopoietic hierarchy would be able to give rise to cells characteristic of connective tissues, such as bone, cartilage, adipose, tendon, ligament and others, but not stromal components such as endothelial cells or macrophages [1].”
Stem cell-based tissue engineering with silk biomaterials. (2006, background): “One such example is MSCs, which can be isolated from a wide variety of tissues including bone marrow [116,117], periosteum [118,119], synovium [120], muscle [121–123], adipose tissue [124], lung [125–127], bone [128], deciduous teeth [129], dermis [130], and articular cartilage [131].”